Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Melissa K. Parks"'
Autor:
Lecia V. Sequist, Jeffrey A. Engelman, Andrew R. Allen, Alice T. Shaw, A. John Iafrate, Dora Dias-Santagata, Richard H. DiCecca, Melissa K. Parks, Hillary E. Mulvey, Angel R. Garcia, Mitch Raponi, Alona Muzikansky, Subba Digumarthy, Anuj Kalsy, Elizabeth L. Lockerman, Aaron N. Hata, Linnea Fulton, Mari Mino-Kenudson, Joel W. Neal, Heather A. Wakelee, Chris A. Karlovich, Matthew J. Niederst, Zofia Piotrowska
Supplementary Figure S1. CONSORT diagram. Supplementary Figure S2. Histologic analysis of the pre-rociletinib biopsy from patient 12 (H&E 400x, left panel) demonstrates characteristic adenocarcinoma with an open chromatin pattern, ample cytoplasm and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::437ca3efda6e4b1a14798fe61a036ad6
https://doi.org/10.1158/2159-8290.22530498.v1
https://doi.org/10.1158/2159-8290.22530498.v1
Autor:
Lecia V. Sequist, Jeffrey A. Engelman, Andrew R. Allen, Alice T. Shaw, A. John Iafrate, Dora Dias-Santagata, Richard H. DiCecca, Melissa K. Parks, Hillary E. Mulvey, Angel R. Garcia, Mitch Raponi, Alona Muzikansky, Subba Digumarthy, Anuj Kalsy, Elizabeth L. Lockerman, Aaron N. Hata, Linnea Fulton, Mari Mino-Kenudson, Joel W. Neal, Heather A. Wakelee, Chris A. Karlovich, Matthew J. Niederst, Zofia Piotrowska
Supplementary Figure Legends. Supplementary Table S1. Patient characteristics. Supplementary Table S2. Tissue genotyping analyses. Supplementary Table S3. Allelic Fraction of T790M and maximum reduction in tumor volume in response to rociletinib.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03fcd94a89f7fb896d66c6fc6bab2516
https://doi.org/10.1158/2159-8290.22530501
https://doi.org/10.1158/2159-8290.22530501